Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-013961

LA JOLLA PHARMACEUTICAL CO · LJPC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
Feb 23, 2018
Accepted (ET)
Feb 27, 2018 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 23, 2018P10,000$31.5413A3,450,419IBy LP
Common StockF1Feb 23, 2018P10,000$31.9442A3,460,419IBy LP
Common StockF1Feb 23, 2018P10,000$32.4186A3,470,419IBy LP
Common StockF1Feb 23, 2018P20,000$32.58A3,490,419IBy LP
Common StockF1Feb 23, 2018P10,000$32.3046A3,500,419IBy LP
Common StockF1Feb 26, 2018P10,000$32.916A3,510,419IBy LP
Common StockF1Feb 26, 2018P10,000$32.4821A3,520,419IBy LP
Common StockF1Feb 26, 2018P1,000$32.502A3,521,419IBy LP
Common StockF1Feb 27, 2018P9,000$32.6982A3,530,419IBy LP
Common StockF1Feb 27, 2018P10,000$32.1728A3,540,419IBy LP
Common StockF1Feb 27, 2018P10,000$30.5714A3,550,419IBy LP
Common StockF1Feb 27, 2018P10,000$30.8796A3,560,419IBy LP
Common StockF1Feb 27, 2018P10,000$30.8725A3,570,419IBy LP
Common StockF1Feb 27, 2018P10,000$30.688A3,580,419IBy LP
Common StockF1Feb 27, 2018P10,000$30.6037A3,590,419IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses